ImmunoPrecise Antibodies (IPA) Competitors $0.34 -0.05 (-11.87%) (As of 02:08 PM ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends IPA vs. ANEB, OSTX, CVM, CERO, BRNS, LUMO, RAPT, OKYO, NXTC, and ELEVShould you be buying ImmunoPrecise Antibodies stock or one of its competitors? The main competitors of ImmunoPrecise Antibodies include Anebulo Pharmaceuticals (ANEB), OS Therapies (OSTX), CEL-SCI (CVM), CERo Therapeutics (CERO), Barinthus Biotherapeutics (BRNS), Lumos Pharma (LUMO), RAPT Therapeutics (RAPT), OKYO Pharma (OKYO), NextCure (NXTC), and Elevation Oncology (ELEV). These companies are all part of the "pharmaceutical products" industry. ImmunoPrecise Antibodies vs. Anebulo Pharmaceuticals OS Therapies CEL-SCI CERo Therapeutics Barinthus Biotherapeutics Lumos Pharma RAPT Therapeutics OKYO Pharma NextCure Elevation Oncology ImmunoPrecise Antibodies (NASDAQ:IPA) and Anebulo Pharmaceuticals (NASDAQ:ANEB) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their risk, valuation, profitability, media sentiment, earnings, dividends, analyst recommendations, community ranking and institutional ownership. Does the MarketBeat Community favor IPA or ANEB? ImmunoPrecise Antibodies received 1 more outperform votes than Anebulo Pharmaceuticals when rated by MarketBeat users. Likewise, 90.91% of users gave ImmunoPrecise Antibodies an outperform vote while only 90.00% of users gave Anebulo Pharmaceuticals an outperform vote. CompanyUnderperformOutperformImmunoPrecise AntibodiesOutperform Votes1090.91% Underperform Votes19.09%Anebulo PharmaceuticalsOutperform Votes990.00% Underperform Votes110.00% Do institutionals and insiders hold more shares of IPA or ANEB? 6.7% of ImmunoPrecise Antibodies shares are held by institutional investors. Comparatively, 28.4% of Anebulo Pharmaceuticals shares are held by institutional investors. 6.8% of ImmunoPrecise Antibodies shares are held by company insiders. Comparatively, 85.9% of Anebulo Pharmaceuticals shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth. Do analysts recommend IPA or ANEB? ImmunoPrecise Antibodies currently has a consensus target price of $6.00, indicating a potential upside of 1,664.19%. Anebulo Pharmaceuticals has a consensus target price of $8.00, indicating a potential upside of 429.80%. Given ImmunoPrecise Antibodies' higher probable upside, research analysts clearly believe ImmunoPrecise Antibodies is more favorable than Anebulo Pharmaceuticals.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score ImmunoPrecise Antibodies 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00Anebulo Pharmaceuticals 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 Is IPA or ANEB more profitable? Anebulo Pharmaceuticals has a net margin of 0.00% compared to ImmunoPrecise Antibodies' net margin of -114.67%. ImmunoPrecise Antibodies' return on equity of -65.37% beat Anebulo Pharmaceuticals' return on equity.Company Net Margins Return on Equity Return on Assets ImmunoPrecise Antibodies-114.67% -65.37% -40.29% Anebulo Pharmaceuticals N/A -184.40%-158.14% Does the media refer more to IPA or ANEB? In the previous week, Anebulo Pharmaceuticals had 5 more articles in the media than ImmunoPrecise Antibodies. MarketBeat recorded 5 mentions for Anebulo Pharmaceuticals and 0 mentions for ImmunoPrecise Antibodies. ImmunoPrecise Antibodies' average media sentiment score of 0.00 beat Anebulo Pharmaceuticals' score of -0.36 indicating that ImmunoPrecise Antibodies is being referred to more favorably in the media. Company Overall Sentiment ImmunoPrecise Antibodies Neutral Anebulo Pharmaceuticals Neutral Which has more volatility & risk, IPA or ANEB? ImmunoPrecise Antibodies has a beta of 0.13, meaning that its share price is 87% less volatile than the S&P 500. Comparatively, Anebulo Pharmaceuticals has a beta of -1, meaning that its share price is 200% less volatile than the S&P 500. Which has higher earnings and valuation, IPA or ANEB? Anebulo Pharmaceuticals has lower revenue, but higher earnings than ImmunoPrecise Antibodies. Anebulo Pharmaceuticals is trading at a lower price-to-earnings ratio than ImmunoPrecise Antibodies, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioImmunoPrecise Antibodies$18.16M0.54-$20.13M-$0.78-0.44Anebulo PharmaceuticalsN/AN/A-$8.20M-$0.30-5.03 SummaryImmunoPrecise Antibodies beats Anebulo Pharmaceuticals on 10 of the 16 factors compared between the two stocks. Ad Darwin2025 AI Stock Picks: 2 Hidden Gems Under $10/ShareThe AI sector continues to make waves as we move into 2025, and now is a prime opportunity to get involved—without stretching your budget! We’ve just uncovered 2 promising AI stocks trading for under $10/share, and they’re positioned for impressive growth in the coming months.👉[Click here to get your FREE report delivered instantly!] Get ImmunoPrecise Antibodies News Delivered to You Automatically Sign up to receive the latest news and ratings for IPA and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart IPA vs. The Competition Export to ExcelMetricImmunoPrecise AntibodiesPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$9.81M$6.53B$5.10B$8.84BDividend YieldN/A8.11%5.04%4.07%P/E Ratio-0.445.5095.1214.22Price / Sales0.54375.021,217.3088.42Price / CashN/A52.5939.4936.27Price / Book0.3710.276.976.37Net Income-$20.13M$153.22M$118.73M$225.56M7 Day Performance-26.05%-1.19%-1.22%-0.02%1 Month Performance-36.43%-6.71%-3.07%2.04%1 Year Performance-73.64%32.39%32.52%28.00% ImmunoPrecise Antibodies Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)IPAImmunoPrecise Antibodies2.0348 of 5 stars$0.34-11.9%$6.00+1,664.2%-72.2%$9.81M$18.16M-0.4480ANEBAnebulo Pharmaceuticals2.5152 of 5 stars$1.51-0.7%$8.00+429.8%-30.9%$39.15MN/A0.004Analyst ForecastShort Interest ↓News CoverageGap DownHigh Trading VolumeOSTXOS TherapiesN/A$1.83+5.8%N/AN/A$38.76MN/A0.00N/ACVMCEL-SCIN/A$0.60-4.4%N/A-74.0%$38.29MN/A0.0043Analyst DowngradeCEROCERo TherapeuticsN/A$0.25+1.6%N/AN/A$37.98MN/A0.008Gap DownBRNSBarinthus Biotherapeutics1.658 of 5 stars$0.96+6.2%$5.83+510.8%-69.1%$37.76M$800,000.00-0.60107Analyst ForecastLUMOLumos Pharma3.2177 of 5 stars$4.33+0.2%$8.63+99.2%+41.2%$37.45M$2.05M0.0030High Trading VolumeRAPTRAPT Therapeutics4.5983 of 5 stars$1.05-1.9%$9.50+804.8%-92.3%$36.71M$1.53M0.0080OKYOOKYO Pharma2.1572 of 5 stars$1.07-0.5%$7.00+557.3%-38.2%$36.04MN/A0.007NXTCNextCure4.4003 of 5 stars$1.28-1.5%$4.00+212.5%+4.8%$35.85MN/A-0.6290ELEVElevation Oncology2.0229 of 5 stars$0.60+3.5%$7.80+1,197.4%+24.0%$35.54MN/A0.0040Gap Up Related Companies and Tools Related Companies Anebulo Pharmaceuticals Alternatives OS Therapies Alternatives CEL-SCI Alternatives CERo Therapeutics Alternatives Barinthus Biotherapeutics Alternatives Lumos Pharma Alternatives RAPT Therapeutics Alternatives OKYO Pharma Alternatives NextCure Alternatives Elevation Oncology Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:IPA) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ImmunoPrecise Antibodies Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share ImmunoPrecise Antibodies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free IPA Stock Alerts